scholarly journals Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone

2019 ◽  
Vol 26 (6) ◽  
pp. 637-642 ◽  
Author(s):  
Sebastian Mirkin ◽  
Shelli Graham ◽  
Dennis A. Revicki ◽  
Randall H. Bender ◽  
Brian Bernick ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Vasomotor Symptom ◽  
Menopausal Women ◽  
17Β Estradiol

scholarly journals Associations of Erythrocyte Polyunsaturated Fatty Acids with Inflammation and Quality of Life in Post-Menopausal Women with Obesity Completing a Pilot Dietary Intervention

Nutrients ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 1589
Author(s):  
Kylie M. Johnson ◽  
Kellie R. Weinhold ◽  
Rebecca Andridge ◽  
Kristen Arnold ◽  
Panchita P. Chu ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Fatty Acids ◽  
Polyunsaturated Fatty Acids ◽  
Dietary Intervention ◽  
Short Form ◽  
Omega 3 ◽  
Markers Of Inflammation ◽  
Menopausal Women ◽  
Post Menopausal

Study objectives were to determine if erythrocyte omega-3 polyunsaturated fatty acids (n-3 PUFAs) increased in women participating in a dietary intervention that reduced inflammation and body weight and examine PUFA associations with markers of inflammation and quality of life (QOL). An experimental pre-post test, single group design was used. Fifteen post-menopausal women with obesity were enrolled in a 12-week pilot intervention focusing on lowering added sugars and increasing fiber and fish rich in n-3 PUFAs. Measurements included fasting blood samples, anthropometric, lifestyle and dietary data collected at baseline, end of intervention (Week 12) and follow-up (Week 24). Primary outcomes were change in erythrocyte PUFAs and associations between erythrocyte PUFAs, QOL (Short Form 12), and inflammatory markers (interleukin-6, tumor necrosis factor-α-receptor 2, and high sensitivity C-reactive protein (CRP)). Fourteen women completed all intervention visits. Mean erythrocyte docosahexaenoic acid and arachidonic acid (AA) increased at Week 12 and Week 24 (p < 0.001 for both), while eicosapentaenoic acid increased at Week 24 (p < 0.01). After adjustment for percent weight change, week 12 QOL related to physical function was significantly associated with erythrocyte linoleic acid (p < 0.05) and trended toward significant association with EPA (p = 0.051); week 24 CRP was directly associated with erythrocyte AA (p < 0.05). Erythrocyte n-3 PUFAs were not associated with inflammation.

scholarly journals PENILAIAN MENOPAUSAL RATING SCALE (MRS) PADA WANITA MENOPAUSE DI KOTA PEMATANGSIANTAR TAHUN 2019

2019 ◽  
Vol 14 (2) ◽  
pp. 108-113
Author(s):  
Dame Evalina Simangunsong
Keyword(s):  
Quality Of Life ◽  
Health Care ◽  
Rating Scale ◽  
Weight Category ◽  
Physical Complaints ◽  
Difficult Time ◽  
Menopausal Women

Climacterium syndrome is a collection of symptoms experienced by a woman who started at the end of the reproductives until the five years after menopause. This time is a difficult time that women must be passed on with different complaints from each individual. The complaint can be categorized into four complaints such as physical complaints, vasomotor complaints, psychosocial complaints, urogenital complaints. Various complaints experienced can decrease the quality of life of women. Complaints experienced by menopause women can be assessed by Menopausal Rating Scale (MRS).This research is a descriptive type of research with a crosssectional design that aims to determine the description of menopausal complaints experienced by menopausal women in two locations in Pematangsiantar City. The results of the study illustrate that women who are examined in two research locations experience menopausal complaints in the weight category, especially in psychological and urogenital complaints. There is a health care effort in women before the menopause arrives. It is very important to prepare women in receiving the menopause and face the various complaints that will be experienced.

Effect of combined oral contraceptive containing 17β—estradiol on female sexual function, depression and quality of life

2020 ◽  
Vol 18 (6) ◽  
pp. 43-48
Author(s):  
R. I. GABIDULLINA ◽  
◽  
E. I. GALIMYANOVA ◽  
V. I. EREMKINA ◽  
A. M. SHARAPOVA ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Oral Contraceptive ◽  
Female Sexuality ◽  
Reproductive Age ◽  
Women Of Reproductive Age ◽  
Combined Oral Contraceptive ◽  
Function Index ◽  
17Β Estradiol ◽  
Severity Of Depression

The purpose — to evaluate the effect of combined oral contraceptive containing 17β-estradiol on sexuality, severity of depression and quality of life in women of reproductive age. Material and methods. The study involved 53 women in need of contraception aged 18 to 50 years. For the contraceptive purpose women used COC containing 1,5 mg of 17 β -estradiol (E2) and 2,5 mg of nomegestrol acetate (NOMAC) (E2/NOMAC). The questionnaires used in the study are: Female Sexuality Function Index (FSFI-6), Beck Depression Inventory, SF-36 — for evaluating Health-Related Quality of Life. The survey was conducted before and after six months of E2/NOMAC intake; the correlations between the studied parameters and the level of sex hormones in patient’s blood sample were determined. Results. The intake of E2/NOMAC for 6 months did not have negative effect on Female Sexuality Function Index. At the same time, a statistically significant improvement up to 5 points was revealed in such parameters as sexual satisfaction (p = 0,03) and lubrication (p < 0,001). There was a significant decrease in the frequency and severity of depression measured by the Beck Depression Inventory. The Short Form-36 Health Survey revealed a tendency to improve the physical and mental health components of the quality of life (p> 0,05). The change in total testosterone level had a moderate negative relationship with the change in Female Sexuality Function Index (r = — 0,32; p = 0,02). Conclusion. The intake of combined oral contraceptive containing 17β-estradiol for 6 months was associated with no adverse impact on female sexuality and quality of life in women of reproductive age, and reduced the levels of frequency and severity of depression.

scholarly journals Influence of Sleep Disturbances on Quality of Life of Iranian Menopausal Women

2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Zohreh Yazdi ◽  
Khosro Sadeghniiat-Haghighi ◽  
Amir Ziaee ◽  
Khadijeh Elmizadeh ◽  
Masomeh Ziaeeha
Keyword(s):  
Quality Of Life ◽  
Daytime Sleepiness ◽  
Sleep Disturbances ◽  
Negative Impact ◽  
Berlin Questionnaire ◽  
Life Questionnaire ◽  
Cross Sectional ◽  
Obstructive Sleep ◽  
Menopausal Women

Background. Subjective sleep disturbances increase during menopause. Some problems commonly encountered during menopause, such as hot flushes and sweating at night, can cause women to have difficulty in sleeping. These complaints can influence quality of life of menopausal women.Methods. This cross-sectional study was performed on menopausal women attending health centers in Qazvin for periodic assessments. We measured excessive daytime sleepiness by Epworth sleepiness scale (ESS), obstructive sleep apnea (OSA) by the Berlin questionnaire, and insomnia by the insomnia severity index (ISI). We evaluate quality of life by the Menopause specific quality of life questionnaire (MENQOL).Results. A total of 380 menopausal women entered the study. Mean age of participated women was 57.6 ± 6.02. Mean duration of menopause was 6.3 ± 4.6. The frequency of severe and moderate insomnia was 8.4% (32) and 11.8% (45). Severe daytime sleepiness (ESS ≥ 10) was present in 27.9% (80) of the participants. Multivariate analytic results show that insomnia and daytime sleepiness have independent negative impact on each domain and total score of MENQOL questionnaire.Conclusion. According to our findings, EDS and insomnia are frequent in menopausal women. Both EDS and insomnia have significant quality of life impairment.

Sign in / Sign up

Export Citation Format

Share Document